Freenome, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Freenome, Inc. (FRNM) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.34 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-18
- Freenome, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$38.60K.
- Freenome, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $39.94K, a 9.27% increase year-over-year.
- Freenome, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$30.09K.
- Freenome, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was $36.55K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$38.60K derived: S-1 6 month − S-4/A 3 month · filed 2026-08-18 | $1.34K S-1 · filed 2026-08-18 | ||
| 2026-03-31 | $39.94K S-4/A · filed 2026-06-11 | |||
| 2025-12-31 | -$72.47K S-1 · filed 2026-08-18 | |||
| 2025-06-30 | -$30.09K derived: S-1 6 month − S-4/A 3 month · filed 2026-08-18 | $6.46K S-1 · filed 2026-08-18 | ||
| 2025-03-31 | $36.55K S-4/A · filed 2026-06-11 | |||
| 2024-12-31 | $115.01K S-1 · filed 2026-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |